Medicare drug price negotiation passed as part of the 2022 reconciliation bill, allowing the administration to negotiate with drug companies on the prices of 10 high-priced drugs beginning last year.


<div class="paywall-container">
<div class="textbox">
<h4 style="padding: 0 0 20px"> <a href="https://checkout.bostonherald.com/?&amp;g2i_or_o=Internet&amp;g2i_or_p=mg2pw20&amp;g2i_source=MD&amp;g2i_medium=sspw&amp;g2i_campaign=MG2PW20-sspw&amp;returnUrl=https3A2F2Fwww.bostonherald.com2F">Subscribe</a> to continue reading this article.</h4>
<h4> Already subscribed? <a href="https://www.bostonherald.com/login?&amp;returnUrl=https%3A%2F%2Fwww.bostonherald.com%2F2024%2F11%2F18%2Fmedicare-drug-price-negotiations%2F">To login in, click here.</a></h4>
</div>
</div>


Medicare drug price negotiation passed as part of the 2022 reconciliation bill, allowing the administration to negotiate with drug companies on the prices of 10 high-priced drugs beginning last yea…{ai:summary}<p>The 2022 reconciliation bill includes provisions for Medicare to negotiate prices for 10 high-cost drugs, starting last year. This initiative aims to lower prescription drug costs for beneficiaries. </p><p>#health</p>

Future of Medicare drug price negotiations murky under Trump

Subscribe to continue reading this article.

Already subscribed? To login in, click here.

Loading...